WO2019038782A1 - Nouvel agent détoxifiant de composition minérale et procédé d'équilibrage d'une hormone humaine - Google Patents

Nouvel agent détoxifiant de composition minérale et procédé d'équilibrage d'une hormone humaine Download PDF

Info

Publication number
WO2019038782A1
WO2019038782A1 PCT/IN2018/050536 IN2018050536W WO2019038782A1 WO 2019038782 A1 WO2019038782 A1 WO 2019038782A1 IN 2018050536 W IN2018050536 W IN 2018050536W WO 2019038782 A1 WO2019038782 A1 WO 2019038782A1
Authority
WO
WIPO (PCT)
Prior art keywords
bandage
wrap
bandages
detox
user
Prior art date
Application number
PCT/IN2018/050536
Other languages
English (en)
Inventor
Rajesh Chandrakant Soni
Original Assignee
Rajesh Chandrakant Soni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rajesh Chandrakant Soni filed Critical Rajesh Chandrakant Soni
Publication of WO2019038782A1 publication Critical patent/WO2019038782A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof

Definitions

  • the present invention relates to a novel detoxification composition of minerals and method for applying the same for use in practice of detox, slimming and to balance human hormones with wrapping which composition when applied by a body wrapping technique to the skin, will extract waste products and toxins through the pores of the skin cells.
  • the skin is the largest organ of the body and plays an important part in protecting the body from undesirable substances. However it is not completely impermeable.
  • Nava Dayan, Cosmetics & Toiletries magazine (2005) Vol. 120 No. 6 pp 67-76 describes the routes of penetration of substances into the skin. The same routes can facilitate extraction of substances out of the skin. Dirt and excess sebum accumulated on the skin surface or in the pores can disturb the natural barrier function of the skin and cause skin problems such as acne, blocked pores and uneven skin tone.
  • Methods and compositions to remove these substances include cleansing compositions, mechanical cleansers (such as cloths and brushes), mechanical exfoliators and chemical exfoliators.
  • Substances can also enter the body via the penetration routes of the skin, via ingestion or via inhalation. They are then metabolized and either stored in adipose tissue or excreted.
  • the main exposure routes and the fate of toxicants in the body have been documented.
  • Some occupations, and also factors such as lifestyle, diet and genetic disposition involve increased risk of exposure to toxicants.
  • Such factors can be linked to the accumulation of specific toxins and/or their metabolized intermediates in the subcutaneous adipose tissue. For example, exposure to benzene from tobacco smoke, petrol fumes, exhaust fumes or some medicines leads to accumulation of toxic metabolites such as quinone in the body.
  • Ernest Hodgson A Textbook of Modem Toxicology 3rd edition, J.
  • Wiley & Sons Inc Hoboken NJ USA pp4-5 and pp33-73 describes exposure routes and the sources of toxins such as air pollutants, water pollutants, soil pollutants, occupational toxicants, industrial toxicants, toxic metals, agricultural chemicals, food additives, food contaminants, microbial toxins, solvents, drugs, combustion products and cosmetics.
  • toxins such as air pollutants, water pollutants, soil pollutants, occupational toxicants, industrial toxicants, toxic metals, agricultural chemicals, food additives, food contaminants, microbial toxins, solvents, drugs, combustion products and cosmetics.
  • EU-OSHA European Agency for Safety and Health at Work
  • waste substances and toxins may be stored within the fat cells themselves, or in the interstitial fluid which surrounds the fat cells.
  • Stored toxins can cause swelling of the skin and subcutaneous adipose tissue layers, leading to blockages in the lymphatic system and weakening of the tissue structure.
  • toxins Left untreated, toxins accumulate and the effects become increasingly visible as increased body volume, decreased firmness of the skin and subcutaneous adipose tissue, uneven skin surface and uneven skin tone. This accumulation of toxins is a major factor in the formation of protruding fat nodules which become visible at the surface, a condition referred to as cellulite or orange peel skin.
  • Cosmetic methods to remove toxins from the body work by either (i) extracting the substances out of the body via the skin or (ii) stimulating the body's own elimination system utilizing the routes via the liver, the kidneys or the lungs. Breakdown of the subcutaneous adipose tissue increases the amount of toxicants circulating in the body. Breakdown of the subcutaneous adipose tissue occurs during weight loss, but can also be induced by cosmetic methods including cavitation, ultra sound, massage, connective tissue massage, fat-freezing, vacuum massage, infra-red treatment, radio frequency treatment, laser fat reduction and mesotherapy, or by cosmetic ingredients and/or nutritional supplements to stimulate lipolysis.
  • Toxins circulating freely in the body can be detrimental to health, and methods which break down fat can therefore be inadvisable or may involve an unacceptably high risk for a large number of people.
  • J.Chevrier, E.Dewailly, P.Ayotte, P.Mauriege, J-P despres and A.Tremblay, International Journal of Obesity (2000) Vol. 24, No. 10, pp 1272- 1278 describes for example how weight loss in obese individuals increases subcutaneous adipose tissue concentrations of potentially toxic pollutants. Many cosmetic treatments to break down fat cannot be practiced on overweight individuals.
  • Well known cosmetic methods for extracting toxicants and waste substances out of the body via the skin include using the adsorbent and/or absorbent properties of substances and colloid & surface phenomena in treatments such as baths, body wraps and masks.
  • Other methods of extracting toxicants and waste substances out of the body via the skin include inducing transpiration and extraction by reverse iontophoresis.
  • US 4 717 735 describes a body wrap method which achieves a measurable reduction in body volume by removing toxins to reduce swelling of the skin and subcutaneous adipose tissue. The result occurs without weight loss, indicating that the method does not rely on water loss or sweating.
  • a body wrap of this type is commercially available from Silky Oaks BVBA.
  • DE4017172 describes the use of squalane and squalene for the removal of toxins and waste products through the skin.
  • EP2429481 describes methods and compositions for improving skin and body appearance.
  • FR2968213 describes a combination of ingredients for slimming.
  • SI1392335 describes active ingredients for the treatment of cellulite.
  • Phase I involves the transformation of a toxic lipophilic compound to form a reactive molecule. The resulting substance may be much more harmful to the body than the original substance.
  • Phase II involves the addition of a water-soluble group to the molecule, making it hydrophilic and easier to eliminate.
  • Phase III is a pumping mechanism which facilitates removal of these substances from the cells into the surrounding interstitial fluid.
  • Phase I and phase II are regulated by enzymes. Substances which induce phase I enzymes are regarded as harmful to health unless the resulting substances are immediately processed by phase II enzymes and eliminated from the body. Many cosmetic and nutritional ingredients support the detoxification processes.
  • a smaller number of substances can actively increase cellular detoxification by either inducing a phase II enzyme or by increasing phase III activity.
  • the substrates of each phase II enzyme are documented.
  • NADPH quinone oxidoreductase acts on the quinone 1 ,4-Benzoquinone to form the hydroquinone 1,4-Benzenediol.
  • Ernest Hodgson A Textbook of Modem Toxicology 3rd edition, J. Wiley & Sons Inc, Hoboken NJ USA pi 11-148 and D. J.Liska, Alternative Medicine Review (1998) Vol 3, No. 3 ppl87-198 describe the detoxification enzymes and their substrates.
  • Toxins stored in the subcutaneous adipose tissue are known to be immobile and difficult to remove. There is a long sought-after need for improved methods to remove toxins from the skin and from the subcutaneous tissue.
  • the main object of the present invention is to provide a cellular detoxification composition and method of removing toxins and waste substances from the body by using said composition for effectively removing toxins and waste substances from the body for the purpose of (1) Balancing Anti Mullerian Hormones, (2) Balancing Luteinizing Hormones (3) Balancing Follicle Stimulating Hormones, (4) Balancing Prolactin, (5) Balancing Testosterone (6) Balancing Insulin Resistance. (7) Balancing Estrogen level.
  • Balancing Metaltonin Hormones (9) Balancing Serotonin Hormones, (10) Balancing Thtroxin Hormones (11) Balancing Epinephrine Hormones, (12) Balancing Norepinephrine Hormones, (13) Balancing Dopamine Hormones, (14) Balancing Adipneetin Hormones, (15) Balancing Adrenocortocotropic Hormones, (16) Balancing Angiotensinogen Hormones, (17) Balancing Antidiuretic Hormones, (18) Balancing Atrial Natriuretic Hormones, (19)Balancing Calcitonin Hormones, (20) Balancing Choecystokinin Hormones, (21) Balancing Corticotrophin Releasing Hormones, (22) Balancing Erythropoietin Hormones, (23) Balancing Gastrin Hormones, (24) Balancing G
  • Further object of the present invention is to provide a cellular detoxification composition and method thereof that improves cellulite and body contours by reducing the amount of toxins in the subcutaneous adipose tissue without increasing the amount of toxins circulating freely in the body.
  • One more object of the present invention is to provide a cellular detoxification composition and method of removing toxins from the fat cells during weight loss so that the efficiency of a weight loss plan is increased.
  • One more object of the present invention is to provide an improved method of removing toxins from the body without increasing the toxic load on the body.
  • One more object of the present invention is to provide an improved method of treating the subcutaneous fatty tissue by increasing the detoxification processes and the removal of toxins via the skin.
  • One more object of the present invention is to provide an improved method of removing toxins for balancing human hormones by combining a method of extracting toxins with the application of a composition comprising ingredients to stimulate the release of toxins from the fat cells into the interstitial fluid.
  • One more object of the present invention is to provide a cellular detoxification composition which when applied by a body wrapping technique to the skin, extracts waste products and toxins through the pores of the skin cells resulting in inch reduction and detoxification of the desired body parts.
  • One more object of the present invention is to provide a cellular detoxification composition and method for removing toxins by using said composition which provides slimming, firming, tone up body and tightening of skin tissues resulting in inch reduction and detoxification of the desired body parts.
  • Yet another object of present invention is to provide a cellular detoxification composition and process of balancing hormones & slimming using the composition which provides significant inch loss from all over the body from neck to toe.
  • Fig. 1 illustrates leg stages 1 & 2 wrapping techniques according to present invention.
  • Fig. 2 illustrates a leg stage 3 wrapping techniques according to present invention.
  • Fig. 3 illustrates a lower torso criss-cross wrapping techniques according to present invention.
  • Fig. 4 illustrates an upper torso criss-cross wrapping techniques according to present invention.
  • Fig. 5 illustrates a diaper wrap techniques according to present invention.
  • Fig. 6 illustrates a buttock lift skirt wrapping techniques according to present invention.
  • Fig. 7 illustrates a criss-cross to the back wrapping techniques according to present invention.
  • Fig. 8 illustrates a front criss-cross girdle wrapping techniques according to present invention.
  • Fig. 9 illustrates a bust lift wrapping techniques according to present invention.
  • Fig. 10 illustrates an arm wrapping techniques according to present invention.
  • Fig. 11 illustrates a chin wrapping techniques according to present invention.
  • the subject of the invention is generally a human.
  • person as used herein means the subject of the invention.
  • Body means any part or parts of the body including hands, face, feet, hair, scalp and nails.
  • general health means the health of the subject in terms of hormones, medication, medical treatments, disease and genetic disposition.
  • toxins means all toxicants in the body or on the surface of the body, including free radicals and reactive oxygen species.
  • extracting method and “extracting treatment” are used interchangeably and as used herein mean any non-invasive method to remove toxins via the skin from the skin and skin surface, from the pores and from the subcutaneous adipose tissue.
  • cellular detoxification includes phase II detoxification and phase III detoxification.
  • cellular detoxification inducer is a substance capable of increasing cellular detoxification by (i) increasing phase II detoxification by inducing a phase II detoxification enzyme and/or by (ii) increasing phase III detoxification.
  • Cosmetic ingredients are referred to using their INCI name except where a commonly used name is preferable for understanding.
  • the extracting treatment is a body covering.
  • Body covering treatments involve the application of a composition to the whole body or to a part of the body by either applying the composition and then textile to the skin, or by applying minerals to the skin that has been soaked in the composition or a solution or suspension thereof.
  • the composition comprises one or more acceptable ingredients selected from clay, peat, mud, silt, minerals, inorganic salts or a combination thereof.
  • Standard Formulation' as used herein includes ingredients such as those with the INCI names Bentonite, clay, Montmorillonite Clay, Magenesium Chloride, Magnesium Sulphate, Sodium Chloride and Zinc Oxide.
  • the extracting method is a body covering using bandages soaked in a mineral formulation formulation solution, as described in example 1.
  • the cellular detoxification composition is a topical composition comprising a base composition and at least one active ingredient to increase cellular detoxification by (i) increasing phase II detoxification by inducing a phase II detoxification enzyme and/or by (ii) increasing phase III detoxification.
  • the cellular detoxification composition is prepared in the form suitable for application on the skin through rubbing, spraying, patch, compress, textile, bath soak or body covering composition.
  • the cellular detoxification composition can be in the form of a cream, gel, serum, lotion, ointment, mask, aqueous solution, mixture, suspension, emulsion, oil or anhydrous preparation.
  • Skin penetration and product efficiency can be increased by the encapsulation of one or more ingredients, or by the use of iontophoresis.
  • Types of encapsulation include the use of liposomes, microspheres, microemulsions, coated liposomes, phospholipid vectorisation and micelles.
  • Iontophoresis can be carried out using galvanic current, faradic current, microcurrent or a combination thereof. The preferable current is microcurrent because it increases cellular levels of ATP, which aids phase III detoxification.
  • Cellular detoxification can be increased by inducing phase II enzyme activity.
  • the cellular detoxification composition comprises one or more active ingredients to induce a phase II detoxification enzyme.
  • the ability of a substance to induce phase II enzyme activity can be determined using commercially available PCR (Polymerase Chain Reaction) array kits which represent the genes encoding the major classes of phase II enzymes. Cells are cultured in a medium with and without the test substance. After incubation the cells are harvested, the total RNA is extracted, converted into cDNA and then analysed using the PCR cycling program.
  • Phase II detoxification enzymes include the enzyme group Glucuronosyltransferases which regulate Glucuronide conjugation reactions; the enzyme groups Sulfotransferases and Sulfatases which regulate sulfate conjugation reactions; the enzyme group methyltransferases which regulate methylation; the enzyme group Glutathione S -transferases which regulate glutathione conjugation reactions; N-acetyl transferase which regulates acetylation; the enzyme group amino acid transferases which regulate amino acid conjugation reactions; quinone reductase and heme oxygenase.
  • Cellular detoxification can also be increased by increasing phase III detoxification.
  • Substances with the ability to increase phase III detoxification include encapsulated magnesium chloride or encapsulated forms of salts, sea salts or other salt mixtures comprising magnesium. Encapsulation is important for such ingredients.
  • the most suitable encapsulation method is a liposome coated with polysaccharides (Example 1).
  • the ability of a cosmetic ingredient to increase phase III detoxification can be measured by P-glycoprotein (P-gp) activity assessment using a commercially available luminescent Pgp ATPase assay.
  • the cellular detoxification composition comprises one or more ingredients to induce phase III detoxification.
  • the cellular detoxification composition may comprise ingredients to aid the elimination of toxins and increase results by (i) elevating levels of reduced glutathione, (ii) increasing antioxidant activity, (iii) strengthening the blood vessels of the vascular system, (iv)increasing blood flow, (v) stimulating lipolysis and/or (vi) inhibiting adipogenesis.
  • the extracting treatment can be applied to the whole body or to one or more parts of the body.
  • the cellular detoxification composition is applied one or more times to the whole body or to one or more parts of the body.
  • the preferred manner of combining the cellular detoxification composition with an extracting method is described in Example 1.
  • the efficiency of the invention can be determined by assessing one or more results such as body volume reduction, reduction in the thickness of the skin and/or subcutaneous adipose tissue, changes in skin firmness, changes in skin pigmentation, changes in cellulite, changes in skin roughness and changes in efficiency of a weight loss plan.
  • the efficiency of the invention can also be determined by subjective evaluation by the test subject.
  • Body volume reduction can be measured by using a tape measure to measure circumference at fixed points on the body. The points are marked using pen marks to ensure that the position of the measurements is consistent. The measurements are carried out by a person sufficiently skilled and practised to ensure a consistent tension of the tape measure. Body volume reduction can also be determined by using digital photography or optical 3D photography methods.
  • Reduction in the thickness of the skin and subcutaneous adipose tissue can be measured using skinfold calipers at chosen fixed points on the body. The points are marked using pen marks to ensure that the position of the measurements is consistent. The measurements are carried out by a person sufficiently skilled and practised to ensure consistent measurement.
  • Reduction in skin thickness can be measured using commercially available ultra sound imagery equipment.
  • Changes in skin firmness can be determined by using commercially available ultra sound imagery equipment to measure skin density. Changes in skin pigmentation can be visually assessed, or determined by using digital photography or a chromameter. Changes in cellulite can be measured using thermographic film. This is used to grade cellulite and to grade circulation in the skin and subcutaneous adipose tissue layers. Changes in cellulite can also be measured by visual assessment of digital photos. Changes in cellulite can also be measured using visual cellulite grading by a skilled person.
  • Novel detox with mineral composition and process to balancing Human Hormones mainly comprises of:
  • Bentonite in range of 25% to 65%; Magnesium Sulphate in range of 25% to 75%;
  • Magnesium Chloride in range of 10% to 45%
  • Zinc Oxide - 5% - 20%.
  • the present invention provides unique detox with mineral composition treatment, the art of wrapping the human body with elasticated cotton bandages soaked in the said composition which when applied by a body wrapping technique to the skin, extracts waste products and toxins through the pores of the skin cells resulting in inch reduction and detoxification of the desired body parts.
  • the present invention provides slimming, firming, tone up body and tightening of skin tissues by ggtextracting the toxins and waste from body through the skin pores.
  • the wrapping process 'contours' the body which results in better 'shaping' of the body through the cleansing, toning, and tightening of the skin and soft tissue.
  • the present novel detox and mineral composition process using the composition is a safe and effective way for men and women to lose inches/centimeters in approximately two hours.
  • the user is in the wrap itself for 60 minutes whilst the remainder of the time is used for measuring, wrapping and unwrapping. Once wrapped the user is assisted into a vinyl suit which helps retain their body temperature whilst in the wrap. At no time during the wrap process are the natural evaporative processes of the body inhibited.
  • the present novel detox with mineral composition and process to balancing Human Hormones wrap composition is completely safe hypoallergenic.
  • the present wrap process is carried out using 6" (15cm) wide wrap cotton elasticated bandages. These bandages are soaked in the said novel detox with mineral composition and process to balancing human hormones wrap composition.
  • the composition soaked bandages when applied to the body act like a giant poultice. This giant mask effect naturally extracts toxins and poisons from the body's soft tissue (adipose fat tissue).
  • the skin is freed of dead skin cells and the fatty tissue is compacted.
  • the solution should be milky. If it is too thick, the mineral solution will not be able to absorb through to the middle of the bandages efficiently. If the mineral solution is too thin, your user will get a reduced inch loss.
  • the tightness of the overall wrap increases from the ankle to the waist and decreases up through the arms.
  • the bandages are at their tightness from just above the knee to just below the sternum.
  • the number of bandages used in a wrap will vary from 4 - 30 depending on the size of the user.
  • STAGE 1 This is a loose flesh-setting bandage, so don't pull the bandage too tight, but simply place it on the skin.
  • 2 Begin at the heel, (pic.l) placing the end of the bandage under the foot and holding it firmly in both hands so that you always have good control it.
  • 3 As you wrap the bandage over the top of the foot you should overlap the loose end of the bandage.
  • 4 Place the bandage gently on the skin as you wrap up and in towards the heart. 5
  • the back of the knee is a pressure point so never wrap the edge of the bandage across the joint and don't pull the bandage too tightly. Always tuck the end of the bandage in neatly to a prewrapped area.
  • STAGE 2 6. This should be pulled slightly more tightly than the last bandage and is used to shape and firm the calf and lower thigh. 7 Start the bandage at the largest part of the calf, remembering this is a 'contour bandage' so start with a medium tension and wrap tighter as you work up the leg. 8 As you get past the knee you should pull the bandage tighter but only if you are wrapping onto the previous bandage. If you are placing the bandage straight onto the flesh then wrap loosely as you would a 'flesh-setting bandage'. As you go over the back of the knee do not allow the edge of a bandage to cut across the inside of the knee. 9 When you reach the groin area remembers this is a pressure point so be careful not to apply the bandage too tightly or place the edge of the bandage across the joint as this will cause discomfort.
  • the groin area is a pressure point so be careful not to place the edge of the bandage across the joint.
  • This bandage is used to lift under the breast area and complete the esh setting of the torso area and must not be pulled too tightly.
  • This bandage is designed to 'lift' the bottom and atten any bulges around the buttocks and stomach. 2 Have your user stand straight with their legs apart and their side to you. Start by holding the bandage on the hip and wrap through the leg.
  • Diaper Wrap 3 - 4 bandages per
  • the lower back is a pressure point so remember not to apply the bandage too tightly and make sure the user is standing up straight.
  • This bandage lifts each cheek and pulls the lower abdomen in, so that when Finished the user looks like they have a skirt on.
  • Buttock Lift Skirt 1 bandage per side
  • This bandage continues to work on the tummy and waist area, really concentrate on your crosses to create a waist.
  • Front Criss Cross Girdle 1 bandage per side.
  • Bust Lift 1 - 2 bandages per breast
  • Arms 1 bandage per arm.
  • TOP TIP This bandage is optional so always ask if your user would like to target the neck and chin area.
  • the preferred embodiment of the extracting treatment is a body covering using elasticated bandages soaked in a mineral formulation comprising bentonite, magnesium sulfate, magnesium chloride, sodium chloride, zinc oxide and water.
  • the cellular detoxification composition is applied to the skin every 4th day repeated and coverning whole body with soaked elasticated bandages in mineral formulation.
  • the invention (1) Balancing Anti Mullerian Hormones, (2) Balancing Luteinizing Hormones (3) Balancing Follicle Stimulating Hormones, (4) Balancing Prolactin, (5) Balancing Testosterone (6) Balancing Insulin Resistance. (7) Balancing Estrogen level.
  • Balancing Metaltonin Hormones (9) Balancing Serotonin Hormones, (10) Balancing Thtroxin Hormones (11) Balancing Epinephrine Hormones, (12) Balancing Norepinephrine Hormones, (13) Balancing Dopamine Hormones, (14) Balancing Adipneetin Hormones, (15) Balancing Adrenocortocotropic Hormones, (16) Balancing Angiotensinogen Hormones, (17) Balancing Antidiuretic Hormones, (18) Balancing Atrial Natriuretic Hormones, (19)Balancing Calcitonin Hormones, (20) Balancing Choecystokinin Hormones, (21) Balancing Corticotrophin Releasing Hormones, (22) Balancing Erythropoietin Hormones, (23) Balancing Gastrin Hormones, (24) Balancing G
  • the effectiveness of current methods for removing toxins from the skin are improved by the synergistic action of (i) making more toxins available for removal and (ii) by removing the newly available toxins more efficiently from the body so that the body is less taxed by the detoxification process.
  • the invention can be applied to achieve improved results in the areas of (i) body volume reduction, (ii) treatment of cellulite, (iii) improving and firming of the skin and subcutaneous adipose tissue (iv) body contour improvement, (v) removal of toxins from the skin and body.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne l'utilisation d'une composition topique pour équilibrer des hormones humaines. L'objectif de l'invention est d'améliorer l'élimination de toxines et d'équilibrer des hormones en tant que procédés thérapeutiques. Les résultats sont améliorés par l'action synergique des processus consistant à (i) rendre plus de toxines disponibles pour l'élimination et (ii) éliminer les toxines nouvellement disponibles de manière plus efficace du corps de sorte que le corps soit moins sollicité par le processus de détoxication, améliorer le système endocrinien du corps et équilibrer toutes les hormones.
PCT/IN2018/050536 2017-08-22 2018-08-20 Nouvel agent détoxifiant de composition minérale et procédé d'équilibrage d'une hormone humaine WO2019038782A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201721029683 2017-08-22
IN201721029683 2017-08-22

Publications (1)

Publication Number Publication Date
WO2019038782A1 true WO2019038782A1 (fr) 2019-02-28

Family

ID=65439402

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2018/050536 WO2019038782A1 (fr) 2017-08-22 2018-08-20 Nouvel agent détoxifiant de composition minérale et procédé d'équilibrage d'une hormone humaine

Country Status (1)

Country Link
WO (1) WO2019038782A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020202523A1 (fr) * 2019-04-04 2020-10-08 信一 篠崎 Système de traitement de la peau et procédé de traitement de la peau

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009133413A1 (fr) * 2008-04-28 2009-11-05 Novatech D.O.O. Formulation à base de clinoptilolite micronisée en tant qu’agent thérapeutique destiné à éliminer des toxines, des bactéries et des virus de l’organisme

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009133413A1 (fr) * 2008-04-28 2009-11-05 Novatech D.O.O. Formulation à base de clinoptilolite micronisée en tant qu’agent thérapeutique destiné à éliminer des toxines, des bactéries et des virus de l’organisme

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020202523A1 (fr) * 2019-04-04 2020-10-08 信一 篠崎 Système de traitement de la peau et procédé de traitement de la peau

Similar Documents

Publication Publication Date Title
CN1911402A (zh) 男性养生长寿液
CN101842090A (zh) 用于治疗疼痛的局部用组合物
WO2000044346A1 (fr) Abaissement de la temperature de la peau
BE1022293B1 (nl) Methode en composities om toxines te verwijderen uit het lichaam
WO2019038782A1 (fr) Nouvel agent détoxifiant de composition minérale et procédé d'équilibrage d'une hormone humaine
CN101773577A (zh) 用于治疗风湿、关节炎、老年性退行性关节病的关东茶浴包
RU2659026C1 (ru) Способ моделирования и коррекции фигуры и тела человека с использованием бурых морских водорослей
CN102397144B (zh) 养骨健身器
WO2020031194A1 (fr) Utilisation d'une composition minérale pour équilibrer les hormones
Keet The Reflexology Bible: Godsfield Bibles
JP5612095B2 (ja) ネックケアキット
KR101129415B1 (ko) 발 마사지 크림 화장품 조성물
CN110025716A (zh) 一种燥湿健足安神弱酸药浴乳
RU2222316C2 (ru) Лечебно-косметическое средство
Lee Skin cancer
Goldberg Massage and aromatherapy: a practical approach
CN103272001A (zh) 养生美容泡浴草本制剂及其制备方法
Ostrom Massage and the original Swedish movements
JP6656553B1 (ja) 美容方法
CN106136742B (zh) 一种治疗颈椎病的中药药枕
CN107510774A (zh) 一种促进疼痛康复的侗医药
US20070020301A1 (en) Beautification method
CN87216394U (zh) 药物保健羽绒服装
CN105902600A (zh) 一种腰痛灵酒及其制备方法
CN111568964A (zh) 一种腹部靓肤按摩油及其制备方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18849369

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18849369

Country of ref document: EP

Kind code of ref document: A1